EUVIMEDEUVIMED entdecken
Open Access

The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression

Ciara L Flynn iD, Gary E Markey iD, Viola Neudecker iD, Charlotte Farrelly iD, Glenn T Furuta iD, Holger K Eltzschig, Joanne C Masterson, Eóin N McNamee iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2400129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Ciara L Flynn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mucosal Immunology Research Laboratory, Kathleen Lonsdale Institute for Human Health Research, Department of Biology, Maynooth University, Maynooth, …. Hauptthemen laut MEDLINE: MicroRNAs, Myeloid Cells. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Crohn''''s and Colitis Foundation (CCF), Science Foundation Ireland (SFI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant intestinal inflammation plays a critical role in the development of colitis-associated colorectal cancer (CAC), yet the mechanisms controlling tumor development by the myeloid immune compartment are not fully understood. Although altered microRNA expression is observed in CAC, it is also unclear how myeloid-specific microRNAs impact the inflammatory process that underpins the continuum from ulcerative colitis to tumorigenesis. In this study, we report that miR-223 acts to limit myeloid-driven inflammation in the azoxymethane (AOM)–dextran sodium sulfate (DSS) model of CAC in mice. In this model, miR-223–/y mice present with significantly larger tumors with an enhanced proliferative signature. Immunoprofiling showed that miR-223–/y mice have significantly increased colonic myeloid immune infiltrate (neutrophils, monocytes, and macrophages) following AOM-DSS. This was accompanied by an increased inflammatory chemokine and cytokine signature for monocytes and neutrophils. Bone marrow chimera studies demonstrate that myeloid-expressed miR-223 is responsible for the enhanced tumor proliferation and inflammatory response. RNA sequencing identified several pathways that could be contributing to the development of CAC in miR-223–/y mice, including the IL-6/IL-17a cytokine family and STAT3 signaling. Lastly, neutrophil depletion with an anti-GR1 Ab (Ly6G/Ly6C) during the initial phase of the AOM-DSS model reduced the tumor burden in miR-223–/y mice. Collectively, our data indicate that miR-223 is an important regulator of mucosal inflammation and acts to constrain the progression from ulcerative colitis to CAC by limiting myeloid-associated inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMyeloid CellsAnimalsMiceChemokinesCarcinogenesisMice, Inbred C57BLColitisDextran SulfateAzoxymethaneDisease Models, AnimalColitis-Associated NeoplasmsMice, Knockout

Substanzen

MicroRNAsMIRN223 microRNA, mouseChemokinesDextran SulfateAzoxymethane

Autor:innen und Institutionen

  • Mucosal Immunology Research Laboratory, Kathleen Lonsdale Institute for Human Health Research, Department of Biology, Maynooth University, Maynooth, Ireland.
  • Allergy, Inflammation & Remodelling Research Laboratory, Kathleen Lonsdale Institute for Human Health Research, Department of Biology, Maynooth University, Maynooth, Ireland.
  • Department of Anesthesiology, Columbia University Medical Center, New York, NY.
  • Gastrointestinal Eosinophilic Diseases Program, Digestive Health Institute, Children's Hospital Colorado, Department of Paediatrics, University of Colorado School of Medicine, Aurora, CO.
  • Department of Anaesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX.

ORCID-Profile: Ciara L Flynn, Gary E Markey, Viola Neudecker, Charlotte Farrelly, Glenn T Furuta, Eóin N McNamee

Förderung

  • NIDDK NIH HHS
  • Crohn''''s and Colitis Foundation (CCF)
  • Science Foundation Ireland (SFI)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Flynn, C. L., Markey, G. E., Neudecker, V., Farrelly, C., Furuta, G. T., Eltzschig, H. K., Masterson, J. C., & McNamee, E. N. (2024). The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400129

Vancouver

Flynn CL, Markey GE, Neudecker V, Farrelly C, Furuta GT, Eltzschig HK, et al. The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400129

BibTeX
@article{Flynn2024,
  author = {Flynn, Ciara L and Markey, Gary E and Neudecker, Viola and Farrelly, Charlotte and Furuta, Glenn T and Eltzschig, Holger K and Masterson, Joanne C and McNamee, Eóin N},
  title = {The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2400129}
}
Kostenlos starten →